Cell Therapy
Gene Editing

The Big Commercialisation Survey

9 July 2021

What are the key commercialisation challenges associated with bringing a cell and/or gene therapy to commercial scale?

This industry-wide survey – developed in partnership with Cognate BioServices – aims to understand the commercialisation challenges you’re facing when bringing a cell and gene therapy (CGT) product through clinical development to commercial scale, as well as to provide you with a benchmark against the wider industry.

Plus, watch this space for an infographic of the results! 

This survey has now closed – thank you to everyone who participated. Watch this space for an infographic with the results.